DrugMonitor™ Anti-Bococizumab Antibody (VS-1224-YC212) (CAT#: VS-1224-YC212)

Bococizumab has been used in trials for Dyslipidemia, Hyperlipidemia, Hypercholesterolemia, Cardiovascular Disease, and Heterozygous Familial Hypercholesterolemia treatment and prevention. The DrugMonitor™ Anti-Bococizumab Antibody (VS-1224-YC212) is an anti-drug antibody (ADA) against Bococizumab. This drug-based antibody is raised in mice immunized with the Bococizumab. The anti-Bococizumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Bococizumab in samples.

Specific Inquiry
  • Size:

  • Conjugation:

  • Purity:

  • Datasheet
  • MSDS
  • COA

Specifications

  • Host Animal
  • Mouse
  • Specificity
  • Bococizumab
  • Target
  • Bococizumab
  • Immunogen
  • Bococizumab
  • Type
  • Mouse IgG
  • Species Reactivity
  • Human
  • Purity
  • >95%
  • Purification
  • Protein G
  • Applications
  • ELISA, PK/PD, ADA control
  • Format
  • Liquid
  • Concentration
  • Batch-dependent
  • Buffer
  • PBS, pH 7.4
  • Preservative
  • No preservatives
  • Storage
  • Store at 4°C for 1-2 weeks and at -20°C for 1 year. Avoid repeated freezing and thawing.
  • Generic name
  • Bococizumab
  • Related Disease
  • Dyslipidemia, Hyperlipidemia, Hypercholesterolemia, Cardiovascular Disease, and Heterozygous Familial Hypercholesterolemia treatment and prevention

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "bococizumab"

Anti-Human PCSK9 Recombinant Antibody (Bococizumab)
Recombinant Humanized (from mouse) antibody to Human PCSK9. Bococizumab (codenamed RN316)is a monoclonal antibody against PCSK9 designed to reduce LDL cholesterol
Afuco™ Anti-PCSK9 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H10)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant Humanized (from mouse) antibody to Human PCSK9. It is a monoclonal antibody against PCSK9 designed to reduce LDL cholesterol

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for VS-1224-YC212. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare